223 results on '"A, Swathi"'
Search Results
2. EP1101: PATTERNS AND PREDICTORS OF ADHERENCE TO PRESCRIPTION PROTON PUMP INHIBITOR THERAPY IN A POPULATION OF COMMERCIALLY INSURED BARRETT'S ESOPHAGUS PATIENTS
3. Su1193: INCREASING RATES OF ESOPHAGEAL STRICTURE AND DILATION OVER TWO DECADES IN EOSINOPHILIC ESOPHAGITIS PATIENTS – CHANGING PHENOTYPES OR INCREASING RECOGNITION?
4. Su1184: HIGHER BODY MASS INDEX IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO TOPICAL STEROIDS IN ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS
5. Mo1158: MUTATIONAL LOAD INCREASES WITH WORSENING DYSPLASIA GRADE AND NORMALIZES AFTER ENDOSCOPIC TREATMENT OF DYSPLASTIC BARRETT'S ESOPHAGUS
6. Tu1429 THE USE OF CANNABINOIDS IS ASSOCIATED WITH A LOWER RISK OF PANCREATIC CANCER.
7. Sa1278 INCREASING DISEASE SEVERITY AS MEASURED BY I-SEE IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO TOPICAL STEROIDS IN EOSINOPHILIC ESOPHAGITIS
8. Sa1272 IMPACT OF CANNABIS USE ON PRESENTATION AND TREATMENT RESPONSE IN EOSINOPHILIC ESOPHAGITIS
9. 154 HISTOLOGIC RESPONSE OR ENDOSCOPIC NORMALIZATION AFTER INTITIAL TREATMENT FOR EOSINOPHILIC ESOPHAGITIS IN CHILDREN LEADS TO LESS FIBROSTENOSIS OVER LONG-TERM FOLLOW-UP
10. Tu1271 HIGH PREVALENCE OF ESOPHAGEAL MOTILITY DISORDERS IN PATIENTS WITH RHEUMATIC DISEASES
11. Su1260 RISK FACTORS FOR BARRETT'S ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMA IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX: RESULTS FROM A LARGE POPULATION-BASED DATABASE
12. Su1169 HIDDEN LINK BETWEEN HEPATITIS C INFECTION AND HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC PATIENTS: A NATIONAL INPATIENT SAMPLE ANALYSIS
13. Su1028 ETIOLOGIES AND RACIAL DIFFERENCES OF NON VARICEAL UPPER GI BLEED IN POST LIVER TRANSPLANT PATIENTS
14. Su1022 ASSESSING FOR DISPARITIES IN THE DIAGNOSTIC DELAY IN EOSINOPHILIC ESOPHAGITIS
15. Sa2072 AUTISM SPECTRUM DISORDER IS COMMON IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS AND IMPACTS PRESENTATION AND TREATMENT OUTCOMES
16. Sa1251 DEVELOPMENT AND VALIDATION OF THE “PICK-UP-STRICS” SCORE TO PREDICT FIBROSTENOSIS IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS PRIOR TO ENDOSCOPY
17. Sa1250 DAILY OR TWICE DAILY TREATMENT WITH TOPICAL STEROIDS RESULTS IN SIMILAR RESPONSE IN EOSINOPHILIC ESOPHAGITIS
18. 1288 WEIGHT GAIN IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO DIET THERAPY IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS
19. 98 DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT'S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
20. Mo2027 IMPACT OF METABOLICALLY HEALTHY OBESITY ON POST-ERCP OUTCOMES IN ELDERLY PATIENTS: A NATIONWIDE DATABASE ANALYSIS
21. Mo1471 HEPATITIS B VERSUS HEPATITIS B DELTA CO-INFECTION AND RISK OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC LIVER
22. Su1193: INCREASING RATES OF ESOPHAGEAL STRICTURE AND DILATION OVER TWO DECADES IN EOSINOPHILIC ESOPHAGITIS PATIENTS – CHANGING PHENOTYPES OR INCREASING RECOGNITION?
23. Mo1158: MUTATIONAL LOAD INCREASES WITH WORSENING DYSPLASIA GRADE AND NORMALIZES AFTER ENDOSCOPIC TREATMENT OF DYSPLASTIC BARRETT'S ESOPHAGUS
24. EP1101: PATTERNS AND PREDICTORS OF ADHERENCE TO PRESCRIPTION PROTON PUMP INHIBITOR THERAPY IN A POPULATION OF COMMERCIALLY INSURED BARRETT'S ESOPHAGUS PATIENTS
25. Su1184: HIGHER BODY MASS INDEX IS ASSOCIATED WITH DECREASED TREATMENT RESPONSE TO TOPICAL STEROIDS IN ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS
26. Su178 WIDE-AREA TRANSEPITHELIAL SAMPLING WITH THREE-DIMENSIONAL COMPUTER-ASSISTED ANALYSIS (WATS3D) COMMONLY DETECTS CRYPT DYSPLASIA NOT IDENTIFIED BY FORCEPS BIOPSIES IN THE SURVEILLANCE OF TREATMENT-NAÏVE BARRETT'S ESOPHAGUS.
27. Fr200 OVERLAP OF EOSINOPHILIC ESOPHAGITIS, AUTOIMMUNE, AND CONNECTIVE TISSUE DISORDERS, AND THE IMPACT ON TREATMENT RESPONSE
28. Fr073 ASSOCIATIONS BETWEEN AUTOIMMUNE AND VIRAL RISK FACTORS FOR ACHALASIA: A CASE-CONTROL STUDY
29. Sa183 CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN PATIENTS WITH FUNCTIONAL ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION
30. Fr193 OLDER PATIENTS WITH EOSINOPHILIC ESOPHAGITIS HAVE HIGH RATES OF TREATMENT RESPONSE TO TOPICAL STEROIDS
31. Sa341 ETHNIC DIFFERENCES IN LIVER FIBROSIS DUE TO NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): INFLUENCE OF VARIABLES ASSOCIATED WITH METABOLIC SYNDROME (METS)
32. Fr184 A GAP IN CARE LEADS TO PROGRESSION OF FIBROSIS IN EOSINOPHILIC ESOPHAGITIS PATIENTS
33. 864 ANALYSIS OF A MULTICENTER POST-ABLATION COHORT SUGGESTS RADIOFREQUENCY ABLATION FOR NON-DYSPLASTIC BARRETT'S ESOPHAGUS REMAINS COMMONPLACE
34. Sa1571 DO OUTCOMES DIFFER BETWEEN NAFLD COHORTS FROM THE LOWERMOST INCOME QUARTILE VERSUS THE HIGHEST INCOME QUARTILE? A NATIONWIDE PROPENSITY SCORE-MATCHED ANALYSIS
35. Sa1561 METABOLIC RISK FACTORS FOR HEPATOCELLULAR CARCINOMA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE: A PROSPECTIVE STUDY
36. Mo1112 TIME TO ENDOSCOPY FOR ESOPHAGEAL FOOD IMPACTION DOES NOT IMPACT COMPLICATIONS
37. Sa1321 THE CELL SURFACE MARKER SYNDECAN-1 (CD-138) IS A NOVEL SERUM BIOMARKER FOR DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS: RESULTS FROM A PROSPECTIVE STUDY
38. Sa1320 UTILITY OF IGE BINDING PROTEIN GALECTIN-3 AS A NOVEL SERUM BIOMARKER FOR DIAGNOSIS AND MONITORING OF EOSINOPHILIC ESOPHAGITIS IN A PROSPECTIVE COHORT STUDY
39. Sa1311 CSTB AND FABP5, SPECIFIC TO THE ESOPHAGEAL SQUAMOUS EPITHELIUM, ARE DIFFERENTIALLY EXPRESSED IN SERUM MRNA BETWEEN HISTOLOGICALLY ACTIVE AND INACTIVE PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
40. Sa1284 INCREASING AGE AT THE TIME OF DIAGNOSIS AND EVOLVING PHENOTYPES OF EOSINOPHILIC ESOPHAGITIS: A TWO DECADE EXPERIENCE
41. Sa1287 TOPICAL STEROIDS ARE EFFECTIVE AND SAFE IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS OVER A MEDIAN OF 6.5 YEARS OF CHRONIC USE
42. 463 MEPOLIZUMAB FOR TREATMENT OF ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
43. 464 IMPACT OF UP TO 6 MONTHS OF MEPOLIZUMAB TREATMENT FOR ADOLESCENTS AND ADULTS WITH EOSINOPHILIC ESOPHAGITIS IN THE SECOND PHASE OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
44. Su1500 MOLECULAR ANALYSIS OF EUS-ACQUIRED PANCREATIC CYST FLUID FOR KRAS AND GNAS MUTATIONS FOR DIAGNOSIS OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASIA AND MUCINOUS CYSTIC LESIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS
45. Mo1220 FREQUENCY AND PREDICTORS OF LOSS TO FOLLOW-UP IN PATIENTS AFTER INITIAL DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS
46. Tu1610 ENDOSCOPIC ULTRASOUND (EUS)-GUIDED DRAINAGE OF PANCREATIC FLUID COLLECTIONS USING CAUTERY-ENHANCED LUMEN APPOSING METAL STENT (CE-LAMS): ANALYZING 3.5 YEARS DATA FROM A SINGLE HIGH-VOLUME CENTER
47. Mo1207 HIGH HEALTH CARE UTILIZATION OF ENDOSCOPY AND CLINIC VISITS OVER TIME IN PATIETNS WITH EOSINOPHILIC ESOPHAGITIS – IMPLICATIONS FOR LONG TERM CARE AND EXPECTATIONS FOR A CHRONIC DISEASE
48. Sa1002 PREVALENCE OF ACHALASIA IN THE MEDICARE POPULATION
49. Fr184 A GAP IN CARE LEADS TO PROGRESSION OF FIBROSIS IN EOSINOPHILIC ESOPHAGITIS PATIENTS
50. Sa183 CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES IN PATIENTS WITH FUNCTIONAL ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.